acetylcarnitine has been researched along with (5-(3-thienyl)tetrazol-1-yl)acetic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaya, S; Hamada, Y; Hara, T; Hotta, N; Kasuya, Y; Kato, K; Koh, N; Komori, T; Nakamura, J; Nakashima, E; Naruse, K; Sakakibara, F; Sasaki, H; Takeuchi, N | 1 |
1 other study(ies) available for acetylcarnitine and (5-(3-thienyl)tetrazol-1-yl)acetic acid
Article | Year |
---|---|
Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.
Topics: Acetylcarnitine; Aldehyde Reductase; Animals; Body Weight; Carnitine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Inhibitors; Hemodynamics; Male; Neural Conduction; Polymers; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Tetrazoles; Thiophenes | 1998 |